NEW YORK (GenomeWeb News) – WaferGen Biosystems saw its second-quarter revenues fall 55 percent year over year, while its net loss narrowed sharply, it disclosed after the close of the market on Friday.

In its Form 10-Q filed with the US Securities and Exchange Commission, the Fremont, Calif.-based firm said that revenues for the quarter totaled $20,158, down from $44,905 a year ago, primarily due to lower sales of the Real-Time PCR Chip panels and of the SmartSlide consumables.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.

Jun
19
Sponsored by
ACD

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Jun
21
Sponsored by
Roche

This webinar will provide a detailed look at how a genomics lab implemented next-generation sequencing (NGS) liquid biopsy assays into its in-house clinical research program.